Technical Analysis for APLT - Applied Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 30.47 -2.40% -0.75
APLT closed down 2.4 percent on Friday, July 10, 2020, on 75 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical APLT trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -2.40%
Wide Bands Range Expansion -2.40%
Oversold Stochastic Weakness -2.40%
New Downtrend Bearish -5.81%
200 DMA Support Bullish -5.81%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy. The company’s preclinical stage products include AT-001 for acute myocardial infraction; AT-007 for treating galactosemia; AT-003 to treat diabetic retinopathy; and AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
Biopharmaceutical Organ Systems Diabetes Diabetes Mellitus Cardiovascular Disease Diabetic Retinopathy Diabetic Peripheral Neuropathy Preclinical Stage Products Retinopathy Novel Products Peripheral Neuropathy

Is APLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 57.39
52 Week Low 8.36
Average Volume 226,617
200-Day Moving Average 32.54
50-Day Moving Average 42.08
20-Day Moving Average 38.31
10-Day Moving Average 33.34
Average True Range 3.27
ADX 27.24
+DI 13.53
-DI 31.88
Chandelier Exit (Long, 3 ATRs ) 40.08
Chandelier Exit (Short, 3 ATRs ) 38.27
Upper Bollinger Band 49.68
Lower Bollinger Band 26.94
Percent B (%b) 0.16
BandWidth 59.37
MACD Line -3.33
MACD Signal Line -2.49
MACD Histogram -0.8401
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.20
Resistance 3 (R3) 32.28 31.78 31.91
Resistance 2 (R2) 31.78 31.34 31.74 31.81
Resistance 1 (R1) 31.13 31.07 30.88 31.05 31.72
Pivot Point 30.63 30.63 30.51 30.59 30.63
Support 1 (S1) 29.98 30.19 29.73 29.90 29.22
Support 2 (S2) 29.48 29.92 29.44 29.13
Support 3 (S3) 28.83 29.48 29.03
Support 4 (S4) 28.75